CN Stock MarketDetailed Quotes

688513 Chengdu Easton Biopharmaceuticals

Watchlist

30.80
+0.22+0.72%

Market Closed Dec 27 15:00 CST

5.44BMarket Cap21.75P/E (TTM)

Chengdu Easton Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Easton Biopharmaceuticals Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	370.42M	--
		+25.81%
EPS	--	0.41	--
		--

Analyst Rating

Strong Buy

Dec 27, 2024

Chengdu Easton Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 1.729B	--
--	2024/FY	-- / 1.393B	--
--	2023/FY	1.117B / 1.197B	--
--	2022/FY	1.171B / 1.173B	--
Mar 29, 2022	2021/FY	1.023B / 1.090B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 1.729B--

--2024/FY-- / 1.393B--

--2023/FY1.117B / 1.197B--

--2022/FY1.171B / 1.173B--

Mar 29, 20222021/FY1.023B / 1.090B--

Unlock Free Earnings Estimates

Open Account

Chengdu Easton Biopharmaceuticals Earnings Reports

Yuandong Biology: Report for the third quarter of 2024

Oct 25 00:00

Chengdu Easton Biopharmaceuticals: Half-year report for the year 2024.

Aug 20 00:00

Chengdu Easton Biopharmaceuticals: Summary of Half-Year Report in 2024.

Aug 20 00:00

Yuandong Biology: 2023 Annual Report Summary

Apr 23 00:00

Top CN Stock Gainers

Symbol Price % Chg

Suzhou Industrial Park Heshun Electric

300141

11.14 +20.04%

Guangdong Xiongsu Technology Group

300599

7.67 +20.03%

Sichuan Chuanhuan Technology

300547

24.41 +20.01%

Shanghai Wisdom Information Technology

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 27, 2024

Strong Buy

Strong Buy
61.54%
Buy
38.46%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Investment Theme

Monoclonal Antibody Concept